Twin Lakes Capital Management, LLC Amicus Therapeutics, Inc. Transaction History
Twin Lakes Capital Management, LLC
- $151 Million
- Q4 2024
A detailed history of Twin Lakes Capital Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 6,000 shares of FOLD stock, worth $54,060. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,000
Previous 6,000
-0.0%
Holding current value
$54,060
Previous $64,000
12.5%
% of portfolio
0.04%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$264 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$220 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$218 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$209 Million3.18% of portfolio
-
William Blair Investment Management, LLC Chicago, IL15.6MShares$141 Million0.38% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.53B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...